GZ402671: payments to doctors
Payments that named GZ402671 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $29K
- Providers
- 10
- Transactions
- 36
- Average per transaction
- $806
The per-transaction average — $806 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10 providers the average total is $2,901, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $25,956 | 89.5% |
| Sanofi US Services Inc. | $3,056 | 10.5% |